Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F8YUW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,423
Award facts
- Contract value 100% obligated
- $4,422.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens in 0.5 mL quantities, with a ceiling value of $4,422.80. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by October 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's portfolio includes a comprehensive range of pharmaceutical products spanning multiple therapeutic domains, from specialty medications and vaccines to brand-name and generic drugs. The delivery order for Zepbound, a GLP-1 receptor agonist used for weight management, demonstrates the company's role in supplying contemporary pharmaceutical treatments to support Defense Health Agency and other federal healthcare customers. AmerisourceBergen's consistent receipt of competitively awarded contracts reflects its capability to meet federal procurement requirements across diverse medical product categories and transaction values.
Quick answers
Who was awarded contract SPE2DR26F8YUW?
SPE2DR26F8YUW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26F8YUW worth?
The government has obligated $4,423 on SPE2DR26F8YUW.
Is contract SPE2DR26F8YUW an order under another contract?
Yes. SPE2DR26F8YUW is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8YUW competed?
The extent of competition for SPE2DR26F8YUW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award